Detalles de la búsqueda
1.
Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.
BMC Med Res Methodol
; 17(1): 113, 2017 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728577
2.
Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction.
J Urol
; 184(2): 783-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20639056
3.
Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction.
BJU Int
; 106(2): 287-93, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19888972
4.
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration.
BJU Int
; 106(9): 1332-8, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20497416
5.
Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
BJU Int
; 105(1): 58-66, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20132103
6.
Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo.
Health Qual Life Outcomes
; 7: 13, 2009 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-19226471
7.
Integrating Machine Learning With Microsimulation to Classify Hypothetical, Novel Patients for Predicting Pregabalin Treatment Response Based on Observational and Randomized Data in Patients With Painful Diabetic Peripheral Neuropathy.
Pragmat Obs Res
; 10: 67-76, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802967
8.
Correction: Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy.
PLoS One
; 14(2): e0212959, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30807615
9.
Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy.
Clin Drug Investig
; 39(8): 775-786, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31243706
10.
Comparison of fesoterodine and tolterodine in patients with overactive bladder.
BJU Int
; 102(9): 1128-32, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18647298
11.
Using time series analysis approaches for improved prediction of pain outcomes in subgroups of patients with painful diabetic peripheral neuropathy.
PLoS One
; 13(12): e0207120, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521533
12.
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
J Urol
; 178(6): 2488-94, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17937959
13.
Discriminating between neuropathic pain and sensory hypersensitivity using the Chronic Pain Questions (CPQ).
Postgrad Med
; 129(1): 22-31, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27901398
14.
Psychometric validation of the electronic chronic pain questions (eCPQ) in a primary care setting.
Curr Med Res Opin
; 33(1): 137-148, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27829303
15.
Rethinking chronic pain in a primary care setting.
Postgrad Med
; 128(5): 502-15, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27166559
16.
Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA.
Pain
; 61(3): 401-409, 1995 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-7478683
17.
Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.
Brain Res Mol Brain Res
; 114(2): 154-62, 2003 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12829326
18.
Fesoterodine: a new agent for treating overactive bladder.
Am J Manag Care
; 15(4 Suppl): S115-7, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19355800
19.
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
Eur Urol
; 56(3): 534-41, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19070418
20.
Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*.
Curr Med Res Opin
; 24(12): 3513-21, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19032133